To include your compound in the COVID-19 Resource Center, submit it here.

EC145 regulatory update

Endocyte said it plans to submit applications in the EU for its lead cancer candidate and companion

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE